Distinct from other co-stimulatory antibodies, we found that α4-1BB induced striking upregulation of KLRG1 on CD8+, and to a lesser degree CD4+, effector T-cells in the tumor (Figure 5 and 6). The gene discussed is CD8A; the disease is neoplasm.